Comparative Effectiveness of Management Strategies for Adults With Gastroesophageal Reflux Disease: An Update
Comparative Effectiveness Review Study Criteria (2 of 2)
Eligible studies evaluated in the report on which this CME activity is based included the following: 1) Studies on medical treatment of GERD included randomized controlled trials (RCTs), using a PPI or H2RA to treat acute symptoms or as maintenance therapy. 2) Studies with surgical procedures for GERD included only RCTs or cohort studies examining total (Nissen and Nissen-Rossetti) or partial (Toupet) fundoplication, either as an open or as a laparoscopic procedure. 3) Studies with endoscopic procedures, only RCTs or cohort studies examining products approved in the United States were included.
CME = continuing medical education
GERD = gastroesophageal reflux disease
H2RA = histamine type 2 receptor antagonist
PPI = proton pump inhibitor
- Ip S, Chung M, Moorthy D, et al. Comparative Effectiveness of Management Strategies for Adults With Gastroesophageal Reflux Disease: An Update. Comparative Effectiveness Review No. 29 (Prepared by the Tufts Evidence-based Practice Center under Contract No. HHSA 290-2007-10055-I). Rockville, MD: Agency for Healthcare Research and Quality; September 2011. AHRQ Publication No. 11-EHC049-EF. Available at www.effectivehealthcare.ahrq.gov/gerdupdate.cfm.
Your slide tray is being processed.